M16.9
Conditions
Interventions
Group 1: In patients with hip osteoarthritis who have an artificial hip joint implanted, an instrumented gait analysis with EMG is performed at 2 different times:
1. a few days before the surgical in
Sponsors
Klinik für Unfallchirurgie und Orthopädie, Universitätsklinikum Frankfurt
Eligibility
Sex/Gender
All
Age
30 Years to 85 Years
Inclusion criteria
Inclusion criteria: Indication and performance of a total hip replacement surgery. Free standing and walking without support of aids
Exclusion criteria
Exclusion criteria: BMI = 35; Previous arthroplasty of the hip, knee, or ankle joint; Osteoarthritis in the ipsilateral/contralateral knee joint (Kellgren Lawrence scale >2); Surgical procedures on the musculoskeletal system in the past 6 months; Prior joint infections or destructive rheumatoid arthritis; Neurologic disease (e.g., Parkinson's disease, stroke with paralysis component, muscular dystrophy, epilepsy, multiple sclerosis, paraneoplastic neurologic syndrome (PNS), tremor, Alzheimer's disease, chorea, Huntington's disease, polio, cerebral palsy); Lower extremity injuries; Failed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The identification of patients before surgery who are likely to have an increased risk for developing OA in other joints based on biomechanical gait parameters and / or biomarkers from blood and synovial fluid. | — |
Secondary
| Measure | Time frame |
|---|---|
| Impact of the leg alignment in general and specifically the restoration of the offset and leg length on the development of the abductor force and consequently the development of a healthy gait pattern for all joints | — |
Countries
Germany
Contacts
Public ContactStefan van Drongelen
Klinik für Orthopädie (Friedrichsheim), Universitätsklinikum Frankfurt
Outcome results
None listed